HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.

AuthorsG M Simpson, V Varga
JournalCurrent therapeutic research, clinical and experimental (Curr Ther Res Clin Exp) Vol. 16 Issue 5 Pg. 477-82 (May 1974) ISSN: 0011-393X [Print] United States
PMID4209063 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Benzoates
  • Butyrophenones
  • Piperidines
  • Placebos
  • Tranquilizing Agents
Topics
  • Aggression
  • Analysis of Variance
  • Arrhythmias, Cardiac (chemically induced)
  • Basal Ganglia Diseases (chemically induced)
  • Benzoates (administration & dosage, adverse effects, therapeutic use)
  • Butyrophenones (administration & dosage, adverse effects, therapeutic use)
  • Chronic Disease
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Handwriting
  • Humans
  • Male
  • Piperidines (administration & dosage, adverse effects, therapeutic use)
  • Placebos
  • Psychiatric Status Rating Scales
  • Schizophrenia (drug therapy)
  • Statistics as Topic
  • Tranquilizing Agents (administration & dosage, adverse effects, therapeutic use)
  • Tremor (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: